Addendum

Durvalumab (small cell lung cancer) - Addendum to Commission A20-87

Report documents

Federal Joint Committee (G-BA)

2021.04.01 A G-BA decision was published.

Project no.: G21-07
Commission: Commission awarded on 09.02.2021 by the Federal Joint Committee (GBA).
Report type: Addendum
Status: Commission completed
Department/Division: Health Economics
Topic: Airways and respiratory system
Note: If, in the course of the discussions on a commission of the G-BA, a need for further revision arises, IQWiG presents its report in the form of an addendum. The G-BA decides on the number of patients in the SHI target population.

Press contact

+49 221 356850

press@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.